{"gene":"THAP12","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1998,"finding":"P52rIPK (THAP12/PRKRIR) was identified as a novel P58IPK-interacting protein that inhibits P58IPK function, thereby restoring PKR activity and eIF-2alpha phosphorylation. P52rIPK and P58IPK interacted in yeast two-hybrid assays and were recovered as a complex from mammalian cell extracts. In a reconstituted in vitro PKR-regulatory assay, P52rIPK inhibited P58IPK function, resulting in upregulation of PKR-mediated eIF-2alpha phosphorylation and growth suppression.","method":"Interaction cloning, yeast two-hybrid, co-immunoprecipitation from mammalian cells, reconstituted in vitro PKR-regulatory assay, yeast growth suppression assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro assay plus yeast functional assay plus mammalian co-IP, replicated across multiple orthogonal methods in a single rigorous study","pmids":["9447982"],"is_preprint":false},{"year":2002,"finding":"The 114 amino acid charged domain of P52rIPK (THAP12) is necessary and sufficient for interaction with P58IPK, binding specifically to P58IPK TPR domain 7 (adjacent to the TPR motif required for PKR interaction). Both the P52rIPK charged domain and P58IPK TPR7 were required for downstream control of PKR activity, eIF-2alpha phosphorylation, and cell growth. P52rIPK and P58IPK formed a stable intracellular complex during the acute response to cytoplasmic stress induced by various stimuli.","method":"Domain deletion/mutagenesis, in vitro binding assays, cell growth assays, PKR activity and eIF-2alpha phosphorylation assays, co-immunoprecipitation under stress conditions","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis defining minimal domain, in vitro binding, functional assays for PKR/eIF-2alpha, multiple orthogonal methods in one study","pmids":["12269832"],"is_preprint":false},{"year":2002,"finding":"DAP4 (THAP12/PRKRIR) is a constitutively nuclear polypeptide that homodimerizes through its amino terminus and binds MST1 kinase through its carboxyl-terminal segment. Coexpression of DAP4 with submaximal MST1 enhances MST1-induced apoptosis in a dose-dependent fashion. DAP4 is not significantly phosphorylated by MST1 and does not alter MST1 kinase activity in vitro, but DAP4 binds endogenous and recombinant p53, potentially enabling colocalization of MST1 with p53.","method":"Co-immunoprecipitation in COS-7 cells, leptomycin B nuclear accumulation assay, co-expression apoptosis assay, in vitro kinase assay, p53 binding assay with recombinant proteins","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — reciprocal Co-IP, in vitro kinase assay, nuclear localization by drug treatment, multiple orthogonal methods in one study","pmids":["12384512"],"is_preprint":false},{"year":2005,"finding":"THAP0 (an alias for DAP4/THAP12) was identified as a member of the THAP protein family defined by a zinc-dependent sequence-specific DNA-binding THAP domain containing a C2CH signature. The THAP domain of THAP1 (a related family member) was demonstrated to be a zinc-dependent DNA-binding domain; by implication THAP0/THAP12 shares this domain architecture, qualifying it as a nuclear proapoptotic factor within this family.","method":"Phylogenetic/domain analysis; biochemical characterization of THAP domain zinc-dependence and DNA binding via zinc chelation (1,10-o-phenanthroline), site-directed mutagenesis of C2CH residues, in vitro binding-site selection (THAP1 as representative domain)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous biochemical characterization of the THAP domain but performed on THAP1, not THAP12 directly; THAP12 listed as family member with inferred shared domain","pmids":["15863623"],"is_preprint":false},{"year":2011,"finding":"PRKRIR (THAP12) was identified as a novel RIG-I interacting protein. The C-terminal domain of PRKRIR is required for physical interaction with RIG-I and for signal augmentation. PRKRIR blocks poly-ubiquitination and proteasomal degradation of RIG-I, thereby increasing cellular RIG-I protein levels and synergistically enhancing type I IFN production mediated by signal-activated or constitutively active RIG-I. Overexpression of PRKRIR together with active RIG-I efficiently inhibits virus replication.","method":"Co-immunoprecipitation in HEK293FT cells, domain deletion mapping (C-terminal domain), ubiquitination assay, IFN reporter assay, virus replication assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping, ubiquitination assay, functional IFN/antiviral assay; single lab, multiple methods","pmids":["21910972"],"is_preprint":false},{"year":2024,"finding":"THAP12 interacts with ZFP574 (a zinc finger protein) to form a nuclear complex that promotes the G1-to-S phase transition during cell cycle progression. Mutation of ZFP574 impairs nuclear localization of the ZFP574-THAP12 complex. THAP12 deficiency results in cell cycle arrest and impaired lymphoproliferation. In a Myc-driven B cell leukemia mouse model, disruption of ZFP574-THAP12 complex suppressed malignant B cell growth while largely sparing normal B cells.","method":"Forward genetic screen in mice, co-immunoprecipitation (ZFP574-THAP12 interaction), nuclear localization imaging, cell cycle analysis, conditional/acute gene deletion, targeted protein degradation, in vivo leukemia suppression model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, nuclear localization imaging, cell cycle assays, in vivo genetic models with multiple alleles across multiple methods in one study","pmids":["39047044"],"is_preprint":false},{"year":2026,"finding":"Biallelic loss-of-function variants in THAP12 cause severe developmental and epileptic encephalopathy. Patient-derived compound heterozygous variants reduce THAP12 protein abundance. In mouse models, homozygous or compound heterozygous Thap12 mutations cause embryonic lethality, confirming an essential dosage-sensitive role in early development. Zebrafish thap12 loss-of-function models exhibit microcephaly, brain hypoplasia, abnormal neuronal activity, and increased seizure sensitivity; transcriptomic profiling revealed dysregulation of cell cycle and apoptotic pathways with increased cell death and reduced proliferation. Wild-type human THAP12 mRNA rescued these zebrafish phenotypes, whereas patient-variant alleles failed to rescue.","method":"Whole-genome sequencing of patients, mouse genetic models (homozygous and compound heterozygous), zebrafish loss-of-function models, mRNA rescue experiments with wild-type vs. patient variants, transcriptomic profiling of larval zebrafish brains, cell death/proliferation assays","journal":"medRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic models in two species with rescue experiment; preprint, single lab, not yet peer-reviewed","pmids":["41822681"],"is_preprint":true},{"year":2026,"finding":"THAP12 interacts with LDOC1 in the nucleus of NSCLC cells. THAP12 overexpression increased LDOC1 recovery in nuclear histone fractions. LDOC1 knockdown-induced loss of chromatin-bound H2Bub1 and enhanced chromatin compaction were partially mediated by the LDOC1-THAP12 interaction, placing THAP12 within an epigenetic regulatory axis controlling histone H2B monoubiquitination and chromatin accessibility.","method":"Co-immunoprecipitation, proximity ligation assay, nuclear fractionation, ChIP-seq, ATAC-seq, MNase digestion assay with THAP12 overexpression","journal":"Cell communication and signaling : CCS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus proximity ligation assay plus chromatin assays; single lab, multiple orthogonal methods","pmids":["41484780"],"is_preprint":false}],"current_model":"THAP12 (also known as P52rIPK, DAP4, THAP0, PRKRIR) is a constitutively nuclear, zinc-finger THAP-domain protein that functions at the intersection of innate immune signaling, cell cycle regulation, and chromatin remodeling: its charged domain directly inhibits the PKR-inhibitor P58IPK (binding to P58IPK TPR7) to upregulate PKR activity and eIF-2alpha phosphorylation; it also stabilizes RIG-I by blocking its poly-ubiquitination to enhance type I IFN production; it forms a nuclear complex with ZFP574 that drives G1-to-S cell cycle progression in lymphocytes; it interacts with MST1 and p53 to augment apoptosis; and it participates in LDOC1-mediated chromatin remodeling through regulation of histone H2B monoubiquitination, with biallelic loss-of-function causing embryonic lethality in mice and severe epileptic encephalopathy in humans."},"narrative":{"mechanistic_narrative":"THAP12 (P52rIPK/DAP4/PRKRIR) is a constitutively nuclear zinc-finger protein of the THAP family that operates as a multifunctional adaptor across innate immune signaling, cell cycle control, apoptosis, and chromatin regulation [PMID:9447982, PMID:12384512, PMID:15863623]. Its first-defined activity is as a negative regulator of the PKR inhibitor P58IPK: a 114-residue charged domain binds P58IPK TPR7, relieving P58IPK-mediated inhibition of PKR and thereby promoting eIF-2alpha phosphorylation and growth suppression, with the complex forming acutely during cytoplasmic stress [PMID:9447982, PMID:12269832]. In innate antiviral signaling THAP12 also acts through its C-terminal domain to bind RIG-I and block its poly-ubiquitination and proteasomal degradation, stabilizing RIG-I and synergistically enhancing type I IFN production and viral restriction [PMID:21910972]. THAP12 homodimerizes through its N-terminus and uses its C-terminal segment to bind MST1 kinase and p53, augmenting MST1-induced apoptosis without itself being a kinase substrate [PMID:12384512]. In proliferating cells it forms a nuclear complex with ZFP574 that drives the G1-to-S transition, and loss of THAP12 causes cell cycle arrest and impaired lymphoproliferation; disrupting this complex selectively suppresses Myc-driven B cell leukemia [PMID:39047044]. THAP12 further participates in an LDOC1-dependent chromatin axis regulating histone H2B monoubiquitination and chromatin accessibility [PMID:41484780]. Biallelic loss-of-function variants in THAP12 cause severe developmental and epileptic encephalopathy, and complete loss is embryonic lethal in mice, establishing an essential dosage-sensitive developmental role [PMID:41822681].","teleology":[{"year":1998,"claim":"Establishing THAP12 as a regulator of the PKR/eIF-2alpha stress pathway answered how P58IPK-mediated PKR inhibition is itself controlled.","evidence":"Interaction cloning, yeast two-hybrid, mammalian co-IP, and a reconstituted in vitro PKR-regulatory assay","pmids":["9447982"],"confidence":"High","gaps":["Did not map the binding interface or minimal interacting domain","Physiological stimuli engaging this regulation not defined"]},{"year":2002,"claim":"Defining the minimal charged domain and its P58IPK TPR7 binding site established the molecular basis and stress-dependence of THAP12's control over PKR signaling.","evidence":"Domain deletion/mutagenesis, in vitro binding, PKR/eIF-2alpha activity assays, and co-IP under cytoplasmic stress","pmids":["12269832"],"confidence":"High","gaps":["Structural detail of the charged domain–TPR7 interface not resolved","Range of stress stimuli driving complex assembly not exhaustively defined"]},{"year":2002,"claim":"Identifying THAP12 (DAP4) as a nuclear homodimer binding MST1 and p53 placed it in an apoptotic signaling module distinct from its PKR role.","evidence":"Reciprocal co-IP in COS-7, leptomycin B nuclear accumulation, co-expression apoptosis assays, in vitro kinase assay, and recombinant p53 binding","pmids":["12384512"],"confidence":"High","gaps":["Whether THAP12 bridges MST1 to p53 in cells not directly demonstrated","Endogenous apoptotic context and target genes not identified"]},{"year":2005,"claim":"Classification within the THAP family assigned THAP12 a predicted zinc-dependent sequence-specific DNA-binding domain, framing it as a nuclear DNA-binding factor.","evidence":"Phylogenetic/domain analysis with biochemical zinc-dependence and DNA-binding characterization performed on the related THAP1 domain","pmids":["15863623"],"confidence":"Medium","gaps":["DNA-binding and zinc-dependence shown for THAP1, not THAP12 directly","No THAP12-specific DNA target sequence determined"]},{"year":2011,"claim":"Discovery of RIG-I stabilization revealed a second innate-immune function in which THAP12 enhances type I IFN responses post-translationally.","evidence":"Co-IP in HEK293FT, C-terminal domain mapping, ubiquitination assay, IFN reporter, and virus replication assay","pmids":["21910972"],"confidence":"Medium","gaps":["Mechanism by which THAP12 blocks RIG-I ubiquitination not defined","Endogenous relevance during physiological infection not tested"]},{"year":2024,"claim":"The ZFP574-THAP12 nuclear complex was shown to drive the G1-to-S transition, defining a proliferative role with therapeutic relevance in leukemia.","evidence":"Forward genetic screen, reciprocal co-IP, nuclear localization imaging, cell cycle and lymphoproliferation assays, and an in vivo Myc-driven B cell leukemia model","pmids":["39047044"],"confidence":"High","gaps":["Direct gene targets driving G1/S progression not identified","Relationship between this complex and THAP12's other functions unresolved"]},{"year":2026,"claim":"Identifying LDOC1-dependent control of H2B monoubiquitination placed THAP12 within a chromatin-remodeling axis governing chromatin accessibility.","evidence":"Co-IP, proximity ligation assay, nuclear fractionation, ChIP-seq, ATAC-seq, and MNase assays with THAP12 overexpression in NSCLC cells","pmids":["41484780"],"confidence":"Medium","gaps":["Whether THAP12 directly binds chromatin at affected loci not established","Catalytic basis linking THAP12/LDOC1 to H2Bub1 not defined"]},{"year":2026,"claim":"Biallelic loss-of-function variants were linked to developmental and epileptic encephalopathy, establishing an essential dosage-sensitive role in development.","evidence":"Patient whole-genome sequencing, mouse models showing embryonic lethality, zebrafish loss-of-function models, and wild-type vs. variant mRNA rescue (preprint)","pmids":["41822681"],"confidence":"Medium","gaps":["Preprint, single lab, not yet peer-reviewed","Which molecular function of THAP12 underlies the neurodevelopmental phenotype unresolved"]},{"year":null,"claim":"How THAP12's distinct activities — PKR/RIG-I immune regulation, MST1/p53 apoptosis, ZFP574 cell-cycle drive, and LDOC1 chromatin remodeling — are integrated within one protein remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking the cytoplasmic-stress and nuclear functions","No structural model of the full-length protein or its DNA-binding activity in vivo","Tissue-specific function explaining the neurodevelopmental phenotype not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,5,7]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,5,7]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,4]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2]}],"complexes":["ZFP574-THAP12 complex"],"partners":["P58IPK","RIG-I","MST1","TP53","ZFP574","LDOC1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O43422","full_name":"52 kDa repressor of the inhibitor of the protein kinase","aliases":["58 kDa interferon-induced protein kinase-interacting protein","p58IPK-interacting protein","Death-associated protein 4","THAP domain-containing protein 0","THAP domain-containing protein 12"],"length_aa":761,"mass_kda":87.7,"function":"Upstream regulator of interferon-induced serine/threonine protein kinase R (PKR). May block the PKR-inhibitory function of DNAJC3, resulting in restoration of kinase activity and suppression of cell growth","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/O43422/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/THAP12","classification":"Not Classified","n_dependent_lines":522,"n_total_lines":1208,"dependency_fraction":0.43211920529801323},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/THAP12","total_profiled":1310},"omim":[],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/THAP12"},"hgnc":{"alias_symbol":["P52rIPK","DAP4","THAP0"],"prev_symbol":["PRKRIR"]},"alphafold":{"accession":"O43422","domains":[{"cath_id":"-","chopping":"22-91","consensus_level":"high","plddt":85.7353,"start":22,"end":91},{"cath_id":"3.30.420.40","chopping":"159-187_196-356_695-745","consensus_level":"medium","plddt":89.1909,"start":159,"end":745},{"cath_id":"-","chopping":"370-587","consensus_level":"high","plddt":90.3567,"start":370,"end":587},{"cath_id":"-","chopping":"598-687","consensus_level":"high","plddt":90.7993,"start":598,"end":687}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43422","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43422-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43422-F1-predicted_aligned_error_v6.png","plddt_mean":83.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=THAP12","jax_strain_url":"https://www.jax.org/strain/search?query=THAP12"},"sequence":{"accession":"O43422","fasta_url":"https://rest.uniprot.org/uniprotkb/O43422.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43422/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43422"}},"corpus_meta":[{"pmid":"20061403","id":"PMC_20061403","title":"The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20061403","citation_count":173,"is_preprint":false},{"pmid":"15863623","id":"PMC_15863623","title":"The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15863623","citation_count":126,"is_preprint":false},{"pmid":"12384512","id":"PMC_12384512","title":"Death-associated protein 4 binds MST1 and augments MST1-induced apoptosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12384512","citation_count":78,"is_preprint":false},{"pmid":"9447982","id":"PMC_9447982","title":"Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9447982","citation_count":77,"is_preprint":false},{"pmid":"26857264","id":"PMC_26857264","title":"Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26857264","citation_count":70,"is_preprint":false},{"pmid":"12269832","id":"PMC_12269832","title":"P52rIPK regulates the molecular cochaperone P58IPK to mediate control of the RNA-dependent protein kinase in response to cytoplasmic stress.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12269832","citation_count":23,"is_preprint":false},{"pmid":"35615147","id":"PMC_35615147","title":"RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell Carcinoma.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35615147","citation_count":10,"is_preprint":false},{"pmid":"33308209","id":"PMC_33308209","title":"Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report.","date":"2020","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33308209","citation_count":9,"is_preprint":false},{"pmid":"21910972","id":"PMC_21910972","title":"A protein-kinase, IFN-inducible double-stranded RNA dependent inhibitor and repressor of p58 (PRKRIR) enhances type I IFN-mediated antiviral response through the stability control of RIG-I protein.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21910972","citation_count":6,"is_preprint":false},{"pmid":"37813153","id":"PMC_37813153","title":"Transcriptome analysis of digestive diverticula of Hong Kong oyster (Crassostrea hongkongesis) infected with Vibrio harveyi.","date":"2023","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37813153","citation_count":6,"is_preprint":false},{"pmid":"39047044","id":"PMC_39047044","title":"Disruption of the ZFP574-THAP12 complex suppresses B cell malignancies in mice.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/39047044","citation_count":5,"is_preprint":false},{"pmid":"41093603","id":"PMC_41093603","title":"Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia.","date":"2025","source":"Annals of laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41093603","citation_count":1,"is_preprint":false},{"pmid":"37153000","id":"PMC_37153000","title":"Identification and analysis of hub genes of hypoxia-immunity in type 2 diabetes mellitus.","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37153000","citation_count":1,"is_preprint":false},{"pmid":"41822681","id":"PMC_41822681","title":"Ultra-rare biallelic THAP12 variants cause loss of function and underlie severe epileptic encephalopathy.","date":"2026","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41822681","citation_count":0,"is_preprint":false},{"pmid":"41484780","id":"PMC_41484780","title":"LDOC1 connects histone H2B monoubiquitination to tumor cell plasticity in non-small cell lung cancer.","date":"2026","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/41484780","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10838,"output_tokens":2782,"usd":0.037122,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10067,"output_tokens":3201,"usd":0.06518,"stage2_stop_reason":"end_turn"},"total_usd":0.102302,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"P52rIPK (THAP12/PRKRIR) was identified as a novel P58IPK-interacting protein that inhibits P58IPK function, thereby restoring PKR activity and eIF-2alpha phosphorylation. P52rIPK and P58IPK interacted in yeast two-hybrid assays and were recovered as a complex from mammalian cell extracts. In a reconstituted in vitro PKR-regulatory assay, P52rIPK inhibited P58IPK function, resulting in upregulation of PKR-mediated eIF-2alpha phosphorylation and growth suppression.\",\n      \"method\": \"Interaction cloning, yeast two-hybrid, co-immunoprecipitation from mammalian cells, reconstituted in vitro PKR-regulatory assay, yeast growth suppression assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro assay plus yeast functional assay plus mammalian co-IP, replicated across multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"9447982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The 114 amino acid charged domain of P52rIPK (THAP12) is necessary and sufficient for interaction with P58IPK, binding specifically to P58IPK TPR domain 7 (adjacent to the TPR motif required for PKR interaction). Both the P52rIPK charged domain and P58IPK TPR7 were required for downstream control of PKR activity, eIF-2alpha phosphorylation, and cell growth. P52rIPK and P58IPK formed a stable intracellular complex during the acute response to cytoplasmic stress induced by various stimuli.\",\n      \"method\": \"Domain deletion/mutagenesis, in vitro binding assays, cell growth assays, PKR activity and eIF-2alpha phosphorylation assays, co-immunoprecipitation under stress conditions\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis defining minimal domain, in vitro binding, functional assays for PKR/eIF-2alpha, multiple orthogonal methods in one study\",\n      \"pmids\": [\"12269832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DAP4 (THAP12/PRKRIR) is a constitutively nuclear polypeptide that homodimerizes through its amino terminus and binds MST1 kinase through its carboxyl-terminal segment. Coexpression of DAP4 with submaximal MST1 enhances MST1-induced apoptosis in a dose-dependent fashion. DAP4 is not significantly phosphorylated by MST1 and does not alter MST1 kinase activity in vitro, but DAP4 binds endogenous and recombinant p53, potentially enabling colocalization of MST1 with p53.\",\n      \"method\": \"Co-immunoprecipitation in COS-7 cells, leptomycin B nuclear accumulation assay, co-expression apoptosis assay, in vitro kinase assay, p53 binding assay with recombinant proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reciprocal Co-IP, in vitro kinase assay, nuclear localization by drug treatment, multiple orthogonal methods in one study\",\n      \"pmids\": [\"12384512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"THAP0 (an alias for DAP4/THAP12) was identified as a member of the THAP protein family defined by a zinc-dependent sequence-specific DNA-binding THAP domain containing a C2CH signature. The THAP domain of THAP1 (a related family member) was demonstrated to be a zinc-dependent DNA-binding domain; by implication THAP0/THAP12 shares this domain architecture, qualifying it as a nuclear proapoptotic factor within this family.\",\n      \"method\": \"Phylogenetic/domain analysis; biochemical characterization of THAP domain zinc-dependence and DNA binding via zinc chelation (1,10-o-phenanthroline), site-directed mutagenesis of C2CH residues, in vitro binding-site selection (THAP1 as representative domain)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous biochemical characterization of the THAP domain but performed on THAP1, not THAP12 directly; THAP12 listed as family member with inferred shared domain\",\n      \"pmids\": [\"15863623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PRKRIR (THAP12) was identified as a novel RIG-I interacting protein. The C-terminal domain of PRKRIR is required for physical interaction with RIG-I and for signal augmentation. PRKRIR blocks poly-ubiquitination and proteasomal degradation of RIG-I, thereby increasing cellular RIG-I protein levels and synergistically enhancing type I IFN production mediated by signal-activated or constitutively active RIG-I. Overexpression of PRKRIR together with active RIG-I efficiently inhibits virus replication.\",\n      \"method\": \"Co-immunoprecipitation in HEK293FT cells, domain deletion mapping (C-terminal domain), ubiquitination assay, IFN reporter assay, virus replication assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping, ubiquitination assay, functional IFN/antiviral assay; single lab, multiple methods\",\n      \"pmids\": [\"21910972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"THAP12 interacts with ZFP574 (a zinc finger protein) to form a nuclear complex that promotes the G1-to-S phase transition during cell cycle progression. Mutation of ZFP574 impairs nuclear localization of the ZFP574-THAP12 complex. THAP12 deficiency results in cell cycle arrest and impaired lymphoproliferation. In a Myc-driven B cell leukemia mouse model, disruption of ZFP574-THAP12 complex suppressed malignant B cell growth while largely sparing normal B cells.\",\n      \"method\": \"Forward genetic screen in mice, co-immunoprecipitation (ZFP574-THAP12 interaction), nuclear localization imaging, cell cycle analysis, conditional/acute gene deletion, targeted protein degradation, in vivo leukemia suppression model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, nuclear localization imaging, cell cycle assays, in vivo genetic models with multiple alleles across multiple methods in one study\",\n      \"pmids\": [\"39047044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Biallelic loss-of-function variants in THAP12 cause severe developmental and epileptic encephalopathy. Patient-derived compound heterozygous variants reduce THAP12 protein abundance. In mouse models, homozygous or compound heterozygous Thap12 mutations cause embryonic lethality, confirming an essential dosage-sensitive role in early development. Zebrafish thap12 loss-of-function models exhibit microcephaly, brain hypoplasia, abnormal neuronal activity, and increased seizure sensitivity; transcriptomic profiling revealed dysregulation of cell cycle and apoptotic pathways with increased cell death and reduced proliferation. Wild-type human THAP12 mRNA rescued these zebrafish phenotypes, whereas patient-variant alleles failed to rescue.\",\n      \"method\": \"Whole-genome sequencing of patients, mouse genetic models (homozygous and compound heterozygous), zebrafish loss-of-function models, mRNA rescue experiments with wild-type vs. patient variants, transcriptomic profiling of larval zebrafish brains, cell death/proliferation assays\",\n      \"journal\": \"medRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic models in two species with rescue experiment; preprint, single lab, not yet peer-reviewed\",\n      \"pmids\": [\"41822681\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"THAP12 interacts with LDOC1 in the nucleus of NSCLC cells. THAP12 overexpression increased LDOC1 recovery in nuclear histone fractions. LDOC1 knockdown-induced loss of chromatin-bound H2Bub1 and enhanced chromatin compaction were partially mediated by the LDOC1-THAP12 interaction, placing THAP12 within an epigenetic regulatory axis controlling histone H2B monoubiquitination and chromatin accessibility.\",\n      \"method\": \"Co-immunoprecipitation, proximity ligation assay, nuclear fractionation, ChIP-seq, ATAC-seq, MNase digestion assay with THAP12 overexpression\",\n      \"journal\": \"Cell communication and signaling : CCS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus proximity ligation assay plus chromatin assays; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"41484780\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"THAP12 (also known as P52rIPK, DAP4, THAP0, PRKRIR) is a constitutively nuclear, zinc-finger THAP-domain protein that functions at the intersection of innate immune signaling, cell cycle regulation, and chromatin remodeling: its charged domain directly inhibits the PKR-inhibitor P58IPK (binding to P58IPK TPR7) to upregulate PKR activity and eIF-2alpha phosphorylation; it also stabilizes RIG-I by blocking its poly-ubiquitination to enhance type I IFN production; it forms a nuclear complex with ZFP574 that drives G1-to-S cell cycle progression in lymphocytes; it interacts with MST1 and p53 to augment apoptosis; and it participates in LDOC1-mediated chromatin remodeling through regulation of histone H2B monoubiquitination, with biallelic loss-of-function causing embryonic lethality in mice and severe epileptic encephalopathy in humans.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"THAP12 (P52rIPK/DAP4/PRKRIR) is a constitutively nuclear zinc-finger protein of the THAP family that operates as a multifunctional adaptor across innate immune signaling, cell cycle control, apoptosis, and chromatin regulation [#0, #2, #3]. Its first-defined activity is as a negative regulator of the PKR inhibitor P58IPK: a 114-residue charged domain binds P58IPK TPR7, relieving P58IPK-mediated inhibition of PKR and thereby promoting eIF-2alpha phosphorylation and growth suppression, with the complex forming acutely during cytoplasmic stress [#0, #1]. In innate antiviral signaling THAP12 also acts through its C-terminal domain to bind RIG-I and block its poly-ubiquitination and proteasomal degradation, stabilizing RIG-I and synergistically enhancing type I IFN production and viral restriction [#4]. THAP12 homodimerizes through its N-terminus and uses its C-terminal segment to bind MST1 kinase and p53, augmenting MST1-induced apoptosis without itself being a kinase substrate [#2]. In proliferating cells it forms a nuclear complex with ZFP574 that drives the G1-to-S transition, and loss of THAP12 causes cell cycle arrest and impaired lymphoproliferation; disrupting this complex selectively suppresses Myc-driven B cell leukemia [#5]. THAP12 further participates in an LDOC1-dependent chromatin axis regulating histone H2B monoubiquitination and chromatin accessibility [#7]. Biallelic loss-of-function variants in THAP12 cause severe developmental and epileptic encephalopathy, and complete loss is embryonic lethal in mice, establishing an essential dosage-sensitive developmental role [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing THAP12 as a regulator of the PKR/eIF-2alpha stress pathway answered how P58IPK-mediated PKR inhibition is itself controlled.\",\n      \"evidence\": \"Interaction cloning, yeast two-hybrid, mammalian co-IP, and a reconstituted in vitro PKR-regulatory assay\",\n      \"pmids\": [\"9447982\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Did not map the binding interface or minimal interacting domain\",\n        \"Physiological stimuli engaging this regulation not defined\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defining the minimal charged domain and its P58IPK TPR7 binding site established the molecular basis and stress-dependence of THAP12's control over PKR signaling.\",\n      \"evidence\": \"Domain deletion/mutagenesis, in vitro binding, PKR/eIF-2alpha activity assays, and co-IP under cytoplasmic stress\",\n      \"pmids\": [\"12269832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural detail of the charged domain–TPR7 interface not resolved\",\n        \"Range of stress stimuli driving complex assembly not exhaustively defined\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying THAP12 (DAP4) as a nuclear homodimer binding MST1 and p53 placed it in an apoptotic signaling module distinct from its PKR role.\",\n      \"evidence\": \"Reciprocal co-IP in COS-7, leptomycin B nuclear accumulation, co-expression apoptosis assays, in vitro kinase assay, and recombinant p53 binding\",\n      \"pmids\": [\"12384512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether THAP12 bridges MST1 to p53 in cells not directly demonstrated\",\n        \"Endogenous apoptotic context and target genes not identified\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Classification within the THAP family assigned THAP12 a predicted zinc-dependent sequence-specific DNA-binding domain, framing it as a nuclear DNA-binding factor.\",\n      \"evidence\": \"Phylogenetic/domain analysis with biochemical zinc-dependence and DNA-binding characterization performed on the related THAP1 domain\",\n      \"pmids\": [\"15863623\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"DNA-binding and zinc-dependence shown for THAP1, not THAP12 directly\",\n        \"No THAP12-specific DNA target sequence determined\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery of RIG-I stabilization revealed a second innate-immune function in which THAP12 enhances type I IFN responses post-translationally.\",\n      \"evidence\": \"Co-IP in HEK293FT, C-terminal domain mapping, ubiquitination assay, IFN reporter, and virus replication assay\",\n      \"pmids\": [\"21910972\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which THAP12 blocks RIG-I ubiquitination not defined\",\n        \"Endogenous relevance during physiological infection not tested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The ZFP574-THAP12 nuclear complex was shown to drive the G1-to-S transition, defining a proliferative role with therapeutic relevance in leukemia.\",\n      \"evidence\": \"Forward genetic screen, reciprocal co-IP, nuclear localization imaging, cell cycle and lymphoproliferation assays, and an in vivo Myc-driven B cell leukemia model\",\n      \"pmids\": [\"39047044\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct gene targets driving G1/S progression not identified\",\n        \"Relationship between this complex and THAP12's other functions unresolved\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identifying LDOC1-dependent control of H2B monoubiquitination placed THAP12 within a chromatin-remodeling axis governing chromatin accessibility.\",\n      \"evidence\": \"Co-IP, proximity ligation assay, nuclear fractionation, ChIP-seq, ATAC-seq, and MNase assays with THAP12 overexpression in NSCLC cells\",\n      \"pmids\": [\"41484780\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether THAP12 directly binds chromatin at affected loci not established\",\n        \"Catalytic basis linking THAP12/LDOC1 to H2Bub1 not defined\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Biallelic loss-of-function variants were linked to developmental and epileptic encephalopathy, establishing an essential dosage-sensitive role in development.\",\n      \"evidence\": \"Patient whole-genome sequencing, mouse models showing embryonic lethality, zebrafish loss-of-function models, and wild-type vs. variant mRNA rescue (preprint)\",\n      \"pmids\": [\"41822681\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint, single lab, not yet peer-reviewed\",\n        \"Which molecular function of THAP12 underlies the neurodevelopmental phenotype unresolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How THAP12's distinct activities — PKR/RIG-I immune regulation, MST1/p53 apoptosis, ZFP574 cell-cycle drive, and LDOC1 chromatin remodeling — are integrated within one protein remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No unified model linking the cytoplasmic-stress and nuclear functions\",\n        \"No structural model of the full-length protein or its DNA-binding activity in vivo\",\n        \"Tissue-specific function explaining the neurodevelopmental phenotype not defined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 5, 7]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 5, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\"ZFP574-THAP12 complex\"],\n    \"partners\": [\"P58IPK\", \"RIG-I\", \"MST1\", \"TP53\", \"ZFP574\", \"LDOC1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}